Skip to main content
. 2021 Jan 31;17(7):2279–2288. doi: 10.1080/21645515.2020.1853449

Table 3.

Participants’ attitudes toward COVID-19 and COVID-19 vaccines

      Willingness to receive vaccine
 
Variable Classification N (%) Yes
N (%)
No and unsure
N (%)
P
Views on COVID-19 Serious 1767 (55.3) 1524 (86.2) 243 (13.8) <0.001
  Moderate 1375 (43.0) 1115 (81.1) 260 (18.9)  
  Mild and no idea 53 (1.7) 37 (69.8) 16 (30.2)  
Worry degree of COVID-19 Very worried 807 (25.3) 727 (90.1) 80 (9.9) <0.001
  Somewhat worried 1640 (51.3) 1369 (83.5) 271 (16.5)  
  A little worried 649 (20.3) 510 (78.6) 139 (21.4)  
  Not at all 99 (3.1) 70 (70.7) 29 (29.3)  
Attention frequency Often 1290 (40.4) 1164 (90.2) 126 (9.8) <0.001
  Sometimes 1573 (49.2) 1292 (82.1) 281 (17.9)  
  Rarely 294 (9.2) 201 (68.4) 93 (31.6)  
  Never 38 (1.2) 19 (50.0) 19 (50.0)  
Maximum affordable price Free 605 (18.9) 490 (81.0) 115 (19.0) 0.054
  1–100 RMB 898 (28.1) 766 (85.3) 132 (14.7)  
  101–500 RMB 1218 (38.1) 1017 (83.5) 201 (16.5)  
  501–1000 RMB 302 (9.5) 265 (87.7) 37 (12.3)  
  1001–2000 RMB 101 (3.2) 79 (78.2) 22 (16.9)  
  >2000 RMB 71 (2.2) 59 (83.1) 12 (16.9)  
Priority vaccination population Health care professionals and other high-risk groups 1386 (43.4) 1186 (85.6) 200 (14.4) <0.001
  Elderly and other susceptible groups 528 (16.5) 439 (83.1) 89 (16.9)  
  No distinction and voluntary 1032 (32.3) 819 (79.4) 213 (20.6)  
  No distinction and mandatory for all 225 (7.0) 217 (96.4) 8 (3.6)  
  Other 24 (0.8) 15 (62.5) 9 (37.5)  
Time to market of vaccine Within half a year 505 (15.8) 446 (88.3) 59 (11.7) <0.001
  6 months – 1 year 1475 (46.2) 1287 (87.3) 188 (12.7)  
  1–5 years 868 (27.2) 680 (78.3) 188 (21.7)  
  > 5 years 49 (1.5) 32 (65.3) 17 (34.7)  
  I do not know 298 (9.3) 231 (77.5) 67 (22.5)